-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Global vaccine approval/authorization map
Please select the country/region and language for vaccine authorization status.
Authorization requested
Authorization granted
Doses delivered
Approval requested
Fully approved
All trademarks, names, and logos of partner organizations/entities are owned by such organizations/entities and are being used by Novavax solely for informational purposes. Novavax does not claim any rights in the trademarks, names, and logos of its partner organizations/entities.